Zobrazeno 1 - 10
of 991
pro vyhledávání: '"KUMAR, VIMAL"'
Publikováno v:
Journal of Business & Industrial Marketing, 2024, Vol. 39, Issue 10, pp. 2140-2154.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JBIM-05-2023-0289
Publikováno v:
International Journal of Quality & Reliability Management, 2024, Vol. 41, Issue 8, pp. 2146-2180.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJQRM-12-2022-0366
Publikováno v:
The TQM Journal, 2023, Vol. 36, Issue 7, pp. 2107-2131.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/TQM-11-2022-0324
Autor:
Yadav, Vishwas, Kumar, Vimal, Gahlot, Pardeep, Mittal, Ankesh, Kaswan, Mahender Singh, Garza-Reyes, Jose Arturo, Rathi, Rajeev, Antony, Jiju, Kumar, Abhinav, Owad, Ali Al
Publikováno v:
The TQM Journal, 2023, Vol. 36, Issue 7, pp. 2132-2153.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/TQM-03-2023-0069
Publikováno v:
International Journal of Productivity and Performance Management, 2023, Vol. 73, Issue 7, pp. 2092-2115.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJPPM-06-2023-0292
Publikováno v:
International Journal of Educational Management, 2024, Vol. 38, Issue 4, pp. 916-947.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJEM-01-2023-0028
Autor:
Mark Jones, Gagandeep Kang, Thomas L Snelling, Vivekanand Jha, Vinay Rathore, Stephane Heritier, Meg Jardine, Kapil Soni, James Totterdell, Sradha Kotwal, Guy Thwaites, Cheryl Jones, Carol Pollock, Richard Haynes, Katrina Diamante, Abhinav Bassi, Nikita Bathla, Natalie Staplin, Arlen Wilcox, Ashpak Bangi, Gregory Fox, Atul Jindal, Rui Xie, Daniel Vincent O'Hara, Sanjay D'Cruz, Manish Kumar Jain, Louise Burrell, Sharifah Faridah Syed Omar, Gerard Estivill Mercade, Aishwarya Nair, Annelise Decaria, Nicola Abignano, Sabah Siddiqui, Suprava Patel, Anjulata Sahu, Yasmeen Shaikh, Madhavender Jain, Shivam R Kanje, Sanjeev Kumar Vimal, K. Kalyan Chakravarthy, P. Sathish Babu, Yuvraj Singh Cheema, Merlin Moni, Sivapriya G Nair
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Objective To determine whether a chemokine receptor type 2 antagonist, DMX-200 (repagermanium), in combination with an angiotensin receptor blocker, candesartan, improves clinical outcomes in people with COVID-19.Design Prospective, multicentre, doub
Externí odkaz:
https://doaj.org/article/8a844a0f2dc347f4851d0d3d7af9e15f
Publikováno v:
Journal of Work-Applied Management, 2023, Vol. 16, Issue 1, pp. 142-163.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JWAM-11-2022-0076
Publikováno v:
Construction Innovation, 2023, Vol. 24, Issue 1, pp. 67-105.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/CI-09-2022-0229